Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Clinical trial NCT00330616 · COMPLETED

Trial details

NCT number: NCT00330616
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2006-05-01
Primary completion: 2007-11-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.